DePuy Recalls Orthopedic Knee Sleeve for Potential Device Fractures

WASHINGTON, D.C. – The Food and Drug Administration has notified healthcare providers that DePuy Orthopaedics (NYSE: JNJ) has issued a Class I recall of its LPS Disphyseal Sleeve orthopedic knee implant due to a potential for fracture of the device.

“The LPS Diaphyseal Sleeve Base taper connection may not be sufficient to accommodate potential physiologic loads that may be transferred to the junction during normal gait activities by some patients,” the Feb. 22 announcement says. “This may result in fracture of the sleeve at the taper joint which may also lead to loss of function or loss of limb, infection, …